Novartis Investigative Site

Glendale, California 91206

0 studies enrolling now · 8 studies all time

What they study most

Alzheimer's Disease, Atopic Dermatitis, COVID-19 Pneumonia, Impaired Respiratory Function, Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia, Major Depressive Disorder, Salt-sensitive Hypertension, Schizophrenia

Studies at this site

• A First-in-Human Study of CEE321 in Adult Subjects — Completed
• Study of Efficacy and Safety of MAS825 in Patients With COVID-19 — Completed
• Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia — Completed
• A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients — Completed
• Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder — Completed
• Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age — Completed
• Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension — Completed
• Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients — Completed